Italian COVID-19 vaccine shows strong immune response in mid-stage trialThe vaccine, called GRAd-COV2, induced an antibody response against the SARS-CoV-2 spike protein in over 93 pct of volunteers three weeks after the first dose.Mon Jul 12 2021
